Universal Ibogaine Announces Extension of Convertible Notes Payable and Engagement of Market Maker Firms Life Science Investing
Love Pharma Makes Public Debut in Emerging Sexual Health, Wellness, and Psychedelics Markets Pharmaceutical Investing
Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD Cannabis Investing News
Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scientific Meeting Medical Device Investing
AbbVie to Showcase New Data at the United European Gastroenterology Week Virtual 2021 Biotech Investing
U.S. FDA Approves Kite's Tecartus® as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Biotech Investing
Love Pharma: Bringing Psychedelic Therapies and Pharmaceutical Alternatives to Market Pharmaceutical Investing
ACCELERON PHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of XLRN and Encourages Investors to Contact the Firm Pharmaceutical Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as First-Line Treatment for Patients with Unresectable or Metastatic Melanoma Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy Biotech Investing
